Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Push Biotechnology is a Shanghai-based medical technology company specializing in the development and manufacturing of advanced Point-of-Care Testing (POCT) solutions. The company leverages its proprietary centrifugal microfluidic platform to integrate complex laboratory processes into compact, automated diagnostic chips. Their product portfolio includes automated analyzers and disposable cartridges for a wide range of applications, including infectious disease screening, cardiac marker detection, and inflammation monitoring. By combining microfluidics with molecular and immunological detection methods, Push Biotechnology aims to provide rapid, accurate, and easy-to-use diagnostic tools for hospitals, clinics, and emergency settings. The company's technology significantly reduces the turnaround time for critical clinical decisions in decentralized healthcare environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PUSH Bio-technology.